论文部分内容阅读
目的观察丙种球蛋白辅治小儿重症肺炎的临床效果。方法将94例重症肺炎患儿随机分为A组和B组各47例。A组接受常规治疗,B组在A组治疗基础上加用丙种球蛋白治疗。比较2组临床疗效,观察2组临床症状体征改善时间。结果 A组的总有效率为80.9%低于B组的97.9%,差异有统计学意义(P<0.05)。A组的退热时间、啰音消失时间、喘息消失时间、咳嗽缓解时间及住院时间均长于B组,差异均有统计学意义(P<0.05)。结论丙种球蛋白辅治小儿重症肺炎可更显著地改善病情,且无明显不良反应,值得推广应用。
Objective To observe the clinical effect of gamma globulin on children with severe pneumonia. Methods 94 cases of severe pneumonia were randomly divided into group A and group B 47 cases. Group A received routine treatment, while Group B received gamma globulin treatment based on Group A treatment. The clinical efficacy of the two groups were compared, and the improvement of clinical symptoms and signs in two groups was observed. Results The total effective rate in group A was 80.9% lower than that in group B (97.9%), the difference was statistically significant (P <0.05). A group of fever, rales disappear time, wheezing disappeared time, cough relief time and hospitalization were longer than in group B, the difference was statistically significant (P <0.05). Conclusion Gamma adjuvant treatment of severe pneumonia in children can be more significantly improve the disease, and no obvious adverse reactions, it is worth promoting the application.